Want to see MLEC full AI Analyst Report?
MLEC Stock Chart & Stats
$8.93
-$0.04(-4.25%)
At close: 4:00 PM EST
$8.93
-$0.04(-4.25%)
Day’s Range― - ―
52-Week Range$3.08 - $63.45
Previous CloseN/A
Volume11.69K
Average Volume (3M)209.37K
Market Cap
$4.75M
Enterprise Value$251.75M
Total Cash (Recent Filing)$1.93M
Total Debt (Recent Filing)$22.09M
Price to Earnings (P/E)―
Beta-0.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding726,118
10 Day Avg. Volume506,476
30 Day Avg. Volume209,369
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.62
Price to Sales (P/S)0.12
P/FCF Ratio-1.35
Enterprise Value/Market Cap53.01
Enterprise Value/Revenue32.14
Enterprise Value/Gross Profit-393.66
Enterprise Value/Ebitda-48.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Molecular Farming PlatformMoolec’s core technology engineers crops to produce targeted food ingredients in seeds, a durable competitive advantage: it leverages agricultural scale, existing supply chains and IP, enabling low-cost ingredient supply or licensing revenue as food manufacturers seek alternative proteins.
Rapid Revenue And Margin ImprovementA very large revenue ramp and materially improved gross margin indicate early commercialization traction and improving unit economics. Sustained revenue growth and rising gross margins support longer-term margin recovery and ability to cover fixed costs as scale increases.
Restored Listing Compliance And Equity StrengtheningRegaining compliance and demonstrable equity improvement preserves market access and reduces immediate delisting risk, giving management a longer runway to commercialize products and raise capital. Structural access to U.S. markets supports future financing and partnerships.
Bears Say
Weak Balance Sheet And High LeverageMaterial weakening of equity and elevated debt creates long-term refinancing and solvency risk, reducing financial flexibility. High leverage can constrain investment, increase cost of capital, and pressure strategic options over the next several months as the company scales.
Sustained Cash BurnContinued negative operating and free cash flow implies reliance on external funding to sustain operations and scale. Persistent cash burn heightens dilution or debt-raising risk, potentially delaying commercialization investments or partnership executions in the medium term.
Legal Contingency: Cayman Winding-up PetitionAn active Cayman winding-up petition is a structural legal and governance risk: it can block corporate actions, create contingent liabilities, divert management focus, and impede issuance of shareholder holdback shares, potentially affecting liquidity and stakeholder confidence.
Moolec Science News
MLEC FAQ
What was Moolec Science’s price range in the past 12 months?
Moolec Science lowest stock price was $3.08 and its highest was $63.45 in the past 12 months.
What is Moolec Science’s market cap?
Moolec Science’s market cap is $4.75M.
When is Moolec Science’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Moolec Science’s earnings last quarter?
Currently, no data Available
Is Moolec Science overvalued?
According to Wall Street analysts Moolec Science’s price is currently Overvalued.
Does Moolec Science pay dividends?
Moolec Science does not currently pay dividends.
What is Moolec Science’s EPS estimate?
Moolec Science’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Moolec Science have?
Moolec Science has 726,118 shares outstanding.
What happened to Moolec Science’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Moolec Science?
Currently, no hedge funds are holding shares in MLEC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Moolec Science
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Technical Analysis
AIM ImmunoTech
―
Ensysce Biosciences
―
Cyclerion Therapeutics
―
―
Calidi Biotherapeutics
―
Ownership Overview
―
Insiders
0.01% Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors